drugset / Trial / NCT01476800

A Study to Assess Pharmacokinetic Interaction of Multiple Dose Ketoconazole on Single Dose YM178 Oral Controlled Absorption System (OCAS) in Healthy Adult Volunteers

NCT01476800

Phase 1 Completed 24 enrolled Astellas Pharma Inc
Non-randomizedCrossoverOpen-label

Summary

The purpose of this study is to assess the pharmacokinetic interaction of multiple-dose ketoconazole on single-dose YM178 OCAS and the safety and tolerability of YM178 OCAS alone and in combination with ketoconazole in healthy adult volunteers.

Timeline

Start
2006-07
Primary completion
2006-11
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketoconazole Small molecule Oral
Subject Mirabegron Other / unclassified Oral

Indications

No indication recorded.